Curative Biotechnology Inc (CUBT)

[Wrangler1]

I am basing my estimates on the company’s two year time horizon to bring drug solutions to some kind of monetization event, which is their stated business model. If I recall I believe they gained the worldwide rights to repurpose Metformin into an eye drop in February 2021. The two year time frame would be February 2023. So I backed into the dates. It seems clear to me the delay in the IND had a lot to do with the timing of securing the CRADA in addition to whatever supply issues the company had because of COVID last year.